Admission Serum 25-Hydroxyvitamin D and Survival in Older Hospitalized Adults with Delirium: A Retrospective Cohort Study

Background: The prognostic significance of serum 25-hydroxyvitamin D [25(OH)D] among older inpatients with established delirium remains uncertain. Methods: This retrospective single-center cohort included 184 adults aged ≥65 years with delirium and serum 25(OH)D measured within seven days of admission during the period of 2020–2025. Outcomes were all-cause mortality and hospital length of stay. Vitamin D was modeled continuously in Cox regression; baseline comparisons were exploratory. Results: During follow-up, 47 patients (25.5%) died: 31/120 (25.8%) with 25(OH)D concentrations < 30 ng/mL and 16/64 (25.0%) with concentrations ≥30 ng/mL (log-rank p = 0.731). Median follow-up was 30.4 months (reverse Kaplan–Meier; 95% CI 28.1–34.0). The proportional-hazards-corrected multivariable Cox estimate per 10-ng/mL increase was HR 1.09 (95% CI 0.91–1.30; p = 0.354); the minimally adjusted age–sex–CCI estimate was HR 1.07 (95% CI 0.91–1.26; p = 0.407). Adjusted median length of stay was also not associated with serum 25(OH)D (difference of −0.81 days per 10-ng/mL increase, 95% CI −2.18 to 0.56; p = 0.250). Results were consistent across ward, landmark, spline, ridge-penalized, and additional sensitivity analyses. Other covariate and baseline associations were exploratory. Conclusions: Serum 25(OH)D was not significantly associated with mortality or length of stay in this selected retrospective single-center cohort of hospitalized older adults with documented delirium and timely 25(OH)D measurement. The findings were consistent across multiple sensitivity analyses, although the confidence intervals do not establish equivalence or exclude smaller associations. This study cannot evaluate delirium incidence or the effects of vitamin D supplementation. Substantial cohort exclusions, the moderate sample size, limited mortality events, and unavailable functional and frailty measures restrict generalizability. The null findings are informative within this selected population but should not be generalized beyond it without prospective multicenter validation.

Authors

Institutions

Publication Details

Journal
Diagnostics
Published
2026-11-18
DOI
https://doi.org/10.3390/diagnostics16223853
Primary Topic
Vitamin D Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Admission Serum 25-Hydroxyvitamin D and Survival in Older Hospitalized Adults with Delirium: A Retrospective Cohort Study

Nadya Kagansky, Michal Bitan, Daniel Trotzky, Yochai Levy et al.
1 links
Diagnostics
Vitamin D Research Studies
article

Admission Serum 25-Hydroxyvitamin D and Survival in Older Hospitalized Adults with Delirium: A Retrospective Cohort Study

Nadya Kagansky, Michal Bitan, Daniel Trotzky, Yochai Levy, Erica Pinco, Dana Kagansky, Miya Sharfman, Hadar Vaknin Laufer, Dror Nattel-Wright, Maya Wurman
article en

Abstract

Background: The prognostic significance of serum 25-hydroxyvitamin D [25(OH)D] among older inpatients with established delirium remains uncertain. Methods: This retrospective single-center cohort included 184 adults aged ≥65 years with delirium and serum 25(OH)D measured within seven days of admission during the period of 2020–2025. Outcomes were all-cause mortality and hospital length of stay. Vitamin D was modeled continuously in Cox regression; baseline comparisons were exploratory. Results: During follow-up, 47 patients (25.5%) died: 31/120 (25.8%) with 25(OH)D concentrations < 30 ng/mL and 16/64 (25.0%) with concentrations ≥30 ng/mL (log-rank p = 0.731). Median follow-up was 30.4 months (reverse Kaplan–Meier; 95% CI 28.1–34.0). The proportional-hazards-corrected multivariable Cox estimate per 10-ng/mL increase was HR 1.09 (95% CI 0.91–1.30; p = 0.354); the minimally adjusted age–sex–CCI estimate was HR 1.07 (95% CI 0.91–1.26; p = 0.407). Adjusted median length of stay was also not associated with serum 25(OH)D (difference of −0.81 days per 10-ng/mL increase, 95% CI −2.18 to 0.56; p = 0.250). Results were consistent across ward, landmark, spline, ridge-penalized, and additional sensitivity analyses. Other covariate and baseline associations were exploratory. Conclusions: Serum 25(OH)D was not significantly associated with mortality or length of stay in this selected retrospective single-center cohort of hospitalized older adults with documented delirium and timely 25(OH)D measurement. The findings were consistent across multiple sensitivity analyses, although the confidence intervals do not establish equivalence or exclude smaller associations. This study cannot evaluate delirium incidence or the effects of vitamin D supplementation. Substantial cohort exclusions, the moderate sample size, limited mortality events, and unavailable functional and frailty measures restrict generalizability. The null findings are informative within this selected population but should not be generalized beyond it without prospective multicenter validation.

DiagnosticsVol. 16(22)
Tel Aviv University (IL), College of Management Academic Studies (IL), Tel Aviv Sourasky Medical Center (IL), Assaf Harofeh Medical Center (IL), Shmuel Harofeh Hospital (IL), Ariel University (IL)
Good health and well-being
Vitamin D Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon